Novo Nordisk said Monday it has launched its popular obesity drug Wegovy in China, the world’s second-largest pharmaceuticals market where it estimates more than 180 million people live with obesity.

The use of diabetes and weight-loss medications like Ozempic or Wegovy—called GLP-1 drugs—has exploded in recent years, with ...

Medically reviewed by Jonathan Purtell, RDN Protein is a macronutrient important for muscle building and appetite control, ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...